National Guideline Clearinghouse | Pemetrexed for the first-line treatment of non-small-cell lung cancer.

National Institute for Health and Clinical Excellence (NICE).
Guideline Title
Pemetrexed for the first-line treatment of non-small-cell lung cancer.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Pemetrexed for the first-line treatment of non-small-cell lung cancer. London (UK): National Institute for Health and Clinical Excellence (NICE); 2009 Sep. 32 p. (Technology appraisal guidance; no. 181).

Guideline Status
This is the current release of the guideline.

full-text:
National Guideline Clearinghouse | Pemetrexed for the first-line treatment of non-small-cell lung cancer.